Intellectia LogoIntellectia
Product
Resources
Stock
Crypto
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategy
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns

Resources

Learn
Blog
Earnings
Tutorial
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
StockCryptoPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. BLTE
    4. >
  4. Valuation

Valuation

-
stocks logo
BLTE
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

Is BLTE Overvalued？

BLTE is now in the zone, suggesting that BLTE current forward PE ratio of -45.50 is considered compare with the five-year average of -33.10.
P/E
EV/EBITDA
P/S
P/B
P/E
bubble
P/E

BLTE Competitors Valuation Multiple

P/E
EV/EBITDA
P/S
P/E

P/E Multiple

Earnings Growth
Market Cap
stocks logo
BLTE.O
Belite Bio Inc
loss
Average P/E: 15.49
29.35%
1.94B
stocks logo
SUPN.O
Supernus Pharmaceuticals Inc
15.49
Average P/E: 15.49
1177.55%
1.77B
stocks logo
IDYA.O
IDEAYA Biosciences Inc
loss
Average P/E: 15.49
-186.93%
1.70B
stocks logo
TARS.O
Tarsus Pharmaceuticals Inc
loss
Average P/E: 15.49
1.71B
stocks logo
TVTX.O
Travere Therapeutics Inc
loss
Average P/E: 15.49
37.41%
1.72B
stocks logo
ARQT.O
Arcutis Biotherapeutics Inc
loss
Average P/E: 15.49
1.75B

BLTE Revenue Breakdown & PS Ratio Relation

Currency:USD
By Business
By Region
Composition ()
Name
Revenue
Percentage

BLTE FAQs

Is BLTE currently overvalued based on its P/E ratio?

According to the provided data, BLTE's 5-year historical average forward P/E ratio is -33.10. BLTE forward P/E ratio is -45.50, which is categorized as Undervalued.

What is the significance of the EV/EBITDA ratio for BLTE?

The EV/EBITDA ratio helps assess the company's valuation relative to its earnings before interest, taxes, depreciation, and amortization, providing a clearer picture of its operating performance.

What are the key indicators to watch for BLTE's financial performance?

Key indicators include valuation ratios (P/E, EV/EBITDA, P/FCF), revenue growth, and profitability metrics to assess overall financial health.

BLTE PE Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average PE
-33.10
Current PE
-45.50
Overvalued PE
-23.03
Undervalued PE
-43.18

BLTE EV/EBITDA Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average EV
0.00
Current EV
0.00
Overvalued EV
0.00
Undervalued EV
0.00

BLTE P/S Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00

BLTE Competitors Valuation Multiple

P/E
EV/EBITDA
P/S
P/E

P/E Multiple

Earnings Growth
Market Cap
stocks logo
BLTE.O
Belite Bio Inc
loss
Average P/E: 15.49
29.35%
1.94B
stocks logo
SUPN.O
Supernus Pharmaceuticals Inc
15.49
Average P/E: 15.49
1177.55%
1.77B
stocks logo
IDYA.O
IDEAYA Biosciences Inc
loss
Average P/E: 15.49
-186.93%
1.70B
stocks logo
TARS.O
Tarsus Pharmaceuticals Inc
loss
Average P/E: 15.49
1.71B
stocks logo
TVTX.O
Travere Therapeutics Inc
loss
Average P/E: 15.49
37.41%
1.72B
stocks logo
ARQT.O
Arcutis Biotherapeutics Inc
loss
Average P/E: 15.49
1.75B

BLTE Revenue Breakdown & PS Ratio Relation

Currency:USD
By Business
By Region
Composition ()
Name
Revenue
Percentage

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is BLTE undervalued？Is BLTE overvalued compared to its competitors？

BLTE FAQs

Is BLTE currently overvalued based on its P/E ratio?

According to the provided data, BLTE's 5-year historical average forward P/E ratio is -33.10. BLTE forward P/E ratio is -45.50, which is categorized as Undervalued.

What is the significance of the EV/EBITDA ratio for BLTE?

The EV/EBITDA ratio helps assess the company's valuation relative to its earnings before interest, taxes, depreciation, and amortization, providing a clearer picture of its operating performance.

What are the key indicators to watch for BLTE's financial performance?

Key indicators include valuation ratios (P/E, EV/EBITDA, P/FCF), revenue growth, and profitability metrics to assess overall financial health.

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is BLTE undervalued？Is BLTE overvalued compared to its competitors？
Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI Screener
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free